Literature DB >> 25724905

Extra-anatomic revascularization for preoperative cerebral malperfusion due to distal carotid artery occlusion in acute type A aortic dissection.

Maximilian Luehr1, Christian D Etz2, Michal Nozdrzykowski2, Lukas Lehmkuhl3, Martin Misfeld2, Farhad Bakhtiary2, Michael A Borger4, Friedrich-Wilhelm Mohr2.   

Abstract

OBJECTIVES: Management of patients with acute aortic dissection type A (AADA) and cerebral malperfusion secondary to occlusion or stenosis of the left common carotid artery (LCCA) or right common carotid artery (RCCA) is a significant challenge. The aim of this study is to present our institutional strategy and postoperative results for this high-risk patient cohort.
METHODS: Between November 2005 and July 2013, 23 of 354 consecutively operated AADA patients [median age: 66.3; interquartile range (IQR): 55.2-69.9] suffered from cerebral malperfusion due to bilateral (n = 1) or unilateral occlusion of the LCCA/RCCA (n = 22). AADA repair comprised hemi- (n = 14) or total (n = 9) arch replacement in combination with aortic valve repair (n = 7) or replacement (n = 11), root replacement (n = 15) and coronary bypass (n = 3). Extra-anatomic aorto-carotid bypass was performed in all patients. Aorto-carotid bypass was performed at the beginning of the procedure to allow for unilateral selective cerebral perfusion (n = 17; 73.9%) or during the procedure if persisting malperfusion was suspected by near-infrared spectroscopy (n = 6; 26.1%).
RESULTS: The median follow-up was 15.2 months (IQR: 4.8-34.1) and 100% complete. Median hospital stay and ICU stay were 16.0 (IQR: 12.5-26.0) and 13.7 (IQR: 2.0-16.5) days, respectively. Rethoracotomy for haemorrhage or cardiac tamponade was performed in 6 (26.1%) patients. Other postoperative complications comprised low cardiac output with extracorporeal membrane oxygenation (n = 2; 8.7%), sepsis (n = 4; 17.4%), respiratory insufficiency (n = 10; 43.5%), renal failure with temporary dialysis (n = 7; 30.4%) and visceral malperfusion (n = 2; 8.7%) requiring stent grafting (n = 1) or laparotomy with intestinal resection (n = 1). New stroke with or without permanent sensory or motor deficit was diagnosed in 8 (34.8%) patients. Temporary neurological deficits were seen in 9 (39.1%) individuals. Hospital and 1-year mortality rates were 13.0 and 30.4%, respectively. Overall survival after 36 months of the 23 patients (Group I = Extra-anatomic bypass) versus the remaining 331 AADA patients without distal RCCA/LCCA occlusion (Group II = no extra-anatomic bypass) was 69.6% (n = 16) in Group I vs 72.5% (n = 240) in Group II (P = 0.90).
CONCLUSION: Extra-anatomic bypass for LCCA or RCCA occlusion allows for early selective cerebral perfusion during AADA repair, and may reduce the risk of neurological complications in patients with preoperative cerebral malperfusion.
© The Author 2015. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Entities:  

Keywords:  Carotid cannulation; Cerebral malperfusion; Distal carotid artery occlusion; Neurological complications; Selective cerebral perfusion; Stroke; Type A aortic dissection

Mesh:

Year:  2015        PMID: 25724905     DOI: 10.1093/ejcts/ezv064

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  10 in total

1.  Direct perfusion of the carotid artery in patients with brain malperfusion secondary to acute aortic dissection.

Authors:  Yutaka Okita; Yuki Ikeno; Koki Yokawa; Yojiro Koda; Soichiro Henmi; Yasuko Gotake; Hidekazu Nakai; Takashi Matsueda; Takeshi Inoue; Hiroshi Tanaka
Journal:  Gen Thorac Cardiovasc Surg       Date:  2017-12-28

2.  Dissection of Arch Branches Alone: An Indication for Aggressive Arch Management in Type A Dissection?

Authors:  Elizabeth L Norton; Xiaoting Wu; Linda Farhat; Karen M Kim; Himanshu J Patel; G Michael Deeb; Bo Yang
Journal:  Ann Thorac Surg       Date:  2019-08-09       Impact factor: 4.330

3.  Impact of GERAADA score in patients with acute type A aortic dissection.

Authors:  Kayo Sugiyama; Hirotaka Watanuki; Masato Tochii; Yasuhiro Futamura; Yuka Kitagawa; Satoshi Makino; Wataru Ohashi; Katsuhiko Matsuyama
Journal:  J Cardiothorac Surg       Date:  2022-05-23       Impact factor: 1.522

Review 4.  Surgical treatment of type A acute aortic dissection with cerebral malperfusion: a systematic review.

Authors:  Changtian Wang; Lei Zhang; Tao Li; Zhilong Xi; Haiwei Wu; Demin Li
Journal:  J Cardiothorac Surg       Date:  2022-06-03       Impact factor: 1.522

5.  A new tool in the surgeon's hand-initial experience with a new stent for type A dissection involving the aortic arch.

Authors:  Thorsten Wahlers; Maximilian Luehr
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-07-26

6.  Initial experience with the new type A arch dissection stent: restoration of supra-aortic vessel perfusion.

Authors:  Matteo Montagner; Markus Kofler; Roland Heck; Semih Buz; Christoph Starck; Stephan Kurz; Volkmar Falk; Jörg Kempfert
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-07-26

7.  Surgical reconstruction of the dissected innominate artery using extra-anatomic aorto-axillar bypass.

Authors:  Igor Zivkovic; Slobodan Micovic; Zeljko Bojovic; Miodrag Peric
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-10-04

8.  Preoperative Imaging Risk Findings for Postoperative New Stroke in Patients With Acute Type A Aortic Dissection.

Authors:  Hongliang Zhao; Fan Guo; Jingji Xu; Yuanqiang Zhu; Didi Wen; Weixun Duan; Minwen Zheng
Journal:  Front Cardiovasc Med       Date:  2020-11-30

Review 9.  The cannulation strategy in surgery for acute type A dissection.

Authors:  Tomonobu Abe; Akihiko Usui
Journal:  Gen Thorac Cardiovasc Surg       Date:  2016-09-20

10.  Two Cases Treated by Different Strategies for Common Carotid Artery Dissection with Thrombosis Due to a Type A Aortic Dissection.

Authors:  Wei Ren; Feng Shi; Zhiwei Wang; Jiahui Wang; Jinxing Chang
Journal:  Braz J Cardiovasc Surg       Date:  2020-06-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.